Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2025 Apr;48(4):493-494.
doi: 10.1007/s00270-025-04004-y. Epub 2025 Mar 11.

Commentary on "Hepatocellular Carcinoma with Vascular Invasion Treated with Resin Yttrium-90 Transarterial Radioembolization Using Single Compartment Dosimetry"

Abin Sajan  1 , Kirema Garcia-Reyes  2 , Shamar Young  3 , Zachary Berman  4 , Tyler A Sandow  5 , Junaid Raja  6 , Osman Ahmed  7 , Venkatesh P Krishnasamy  6
Affiliations
Editorial

Commentary on "Hepatocellular Carcinoma with Vascular Invasion Treated with Resin Yttrium-90 Transarterial Radioembolization Using Single Compartment Dosimetry"

Abin Sajan et al. Cardiovasc Intervent Radiol. 2025 Apr.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Declarations. Conflict of interest: The authors declare that they have no conflict of interest. Formal Consent: For this type of study, formal consent is not required. Human or Animals Participants: This article does not contain any studies with human participants or animals performed by any of the authors. Informed Consent: For this type of study, informed consent is not required. Consent for Publications: For this type of study, consent for publication is not required.

References

    1. Salem R, Johnson GE, Kim E, et al. Yttrium-90 radioembolization for the treatment of solitary unresectable HCC: the legacy study. Hepatology. 2021;74(5):2342–52. - DOI - PubMed
    1. Sandow T, Gimenez J, Nunez K, et al. Using voxel-based dosimetry to evaluate sphere concentration and tumor dose in hepatocellular carcinoma treated with yttrium-90 radiation segmentectomy with glass microspheres. J Vasc Interv Radiol. 2024;35(11):1602-1612.e1. - DOI - PubMed
    1. Salem R, Padia SA, Lam M, et al. Clinical, dosimetric, and reporting considerations for Y-90 glass microspheres in hepatocellular carcinoma: updated 2022 recommendations from an international multidisciplinary working group. Eur J Nucl Med Mol Imaging. 2023;50(2):328–43. - DOI - PubMed
    1. Levillain H, Bagni O, Deroose CM, et al. International recommendations for personalised selective internal radiation therapy of primary and metastatic liver diseases with yttrium-90 resin microspheres. Eur J Nucl Med Mol Imaging. 2021;48(5):1570–84. - DOI - PubMed - PMC
    1. Tahir MM, Ali A, Nasser I, et al. Hepatocellular carcinoma with vascular invasion treated with resin yttrium-90 transarterial radioembolization using single compartment dosimetry. Cardio Vascul Interv Radiol. 2025. https://doi.org/10.1007/s00270-024-03933-4 . - DOI

Publication types

LinkOut - more resources